Tenaya Therapeutics Ownership | Who Owns Tenaya Therapeutics?

Tenaya Therapeutics Ownership Summary

Tenaya Therapeutics is owned by 22.03% institutional investors, 1.57% insiders, and 76.39% retail investors. Column group is the largest institutional shareholder, holding 10.91% of TNYA shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 2.66% of its assets in Tenaya Therapeutics shares.

TNYA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Tenaya Therapeutics	22.03%	1.57%	76.39%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Column group	9.40M	10.91%	$13.44M
Casdin capital	6.73M	7.81%	$9.63M
Blackrock funding, inc. /de	5.30M	6.15%	$7.57M
Jpmorgan chase	5.16M	5.98%	$7.37M
Blackrock	4.07M	5.03%	$12.63M
Vanguard group	3.27M	3.80%	$4.68M
Vr adviser	1.56M	1.81%	$2.22M
Ghost tree capital	1.35M	1.67%	$4.18M
Geode capital management	1.27M	1.47%	$1.81M
State street	1.05M	1.30%	$3.25M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Column group	9.40M	24.12%	$13.44M
Ghost tree capital	1.35M	1.31%	$4.18M
Casdin capital	6.73M	0.64%	$9.63M
Stepstone group lp	462.16K	0.58%	$660.89K
Euclidean capital	1.02M	0.20%	$1.45M
Vr adviser	1.56M	0.15%	$2.22M
Alphabet	915.71K	0.08%	$1.31M
Trustees of columbia university in the city of new york	291.83K	0.07%	$417.31K
Ground swell capital	22.26K	0.05%	$31.84K
Atticus wealth management	47.76K	0.02%	$68.30K

Top Buyers

Holder	Shares	% Assets	Change
Jpmorgan chase	5.16M	0.00%	5.13M
Blackrock funding, inc. /de	5.30M	0.00%	1.19M
Ghost tree capital	1.35M	1.31%	575.00K
Ubs group	478.51K	0.00%	452.37K
Trustees of columbia university in the city of new york	291.83K	0.07%	291.83K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-6.98M
Price t rowe associates inc /md/	136.23K	-	-2.89M
Octagon capital advisors lp	-	-	-2.58M
Integral health asset management	-	-	-2.38M
Fmr	34.67K	-	-1.31M

New Positions

Holder	Shares	% Assets	Change	Value
Trustees of columbia university in the city of new york	291.83K	0.07%	291.83K	$417.31K
Sei investments	69.70K	0.00%	69.70K	$99.67K
Engineers gate manager lp	57.00K	0.00%	57.00K	$81.50K
Commonwealth equity services	44.50K	0.00%	44.50K	$64.00K
Spire wealth management	36.90K	0.00%	36.90K	$52.77K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-11.00
Capital performance advisors llp	-12.00
Advisor group	-38.00
Srs capital advisors	-105.00
Federated hermes	-414.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	49	-47.31%	18,984,954	-67.06%	22	0.49%	29	-43.14%	9	-47.06%
Sep 30, 2024	93	-3.13%	57,630,897	1.33%	66	1.36%	51	-5.56%	17	-37.04%
Jun 30, 2024	96	6.67%	56,876,265	1.89%	70	1.23%	54	12.50%	27	3.85%
Mar 31, 2024	90	20.00%	55,822,180	19.53%	75	1.90%	48	33.33%	26	4.00%
Dec 31, 2023	75	-5.06%	46,699,776	-6.12%	63	1.38%	36	-18.18%	25	92.31%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
US Small-Cap Growth II Equity Comp	2.10M	2.66%	-471.71K
T. Rowe Price New Horizons	2.10M	2.65%	-441.00
Vanguard Total Stock Mkt Idx Inv	2.06M	2.39%	-
Fidelity Select Biotechnology	1.75M	2.20%	-
JPMorgan US Small Company L	785.69K	0.91%	-315.70K
iShares Russell 2000 ETF	1.46M	0.90%	-12.60K
Vanguard Institutional Extnd Mkt Idx Tr	741.53K	0.86%	-
JPMorgan Small Cap Value I	1.37M	0.84%	-
T. Rowe Price New Horizons Tr-Z	554.73K	0.70%	9.11K
abrdn Life Sciences Investors	600.70K	0.69%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 10, 2025	Higa Tomohiro	SVP, Finance	Sell	$454.95
Mar 10, 2025	Higa Tomohiro	SVP, Finance	Sell	$333.81
Mar 10, 2025	Higa Tomohiro	SVP, Finance	Sell	$547.55
Mar 10, 2025	Tingley Whittemore	Chief Medical Officer	Sell	$929.82
Mar 10, 2025	Tingley Whittemore	Chief Medical Officer	Sell	$2.19K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	6	8
2024 Q4	-	1
2024 Q3	-	7
2024 Q1	2	7
2023 Q3	-	5

TNYA Ownership FAQ

Who Owns Tenaya Therapeutics?

Tenaya Therapeutics shareholders are primarily institutional investors at 22.03%, followed by 1.57% insiders and 76.40% retail investors. The average institutional ownership in Tenaya Therapeutics's industry, Biotech Stocks , is 68.48%, which Tenaya Therapeutics falls below.

Who owns the most shares of Tenaya Therapeutics?

Tenaya Therapeutics’s largest shareholders are Column group (9.4M shares, 10.91%), Casdin capital (6.73M shares, 7.81%), and Blackrock funding, inc. /de (5.3M shares, 6.15%). Together, they hold 24.87% of Tenaya Therapeutics’s total shares outstanding.

Does Blackrock own Tenaya Therapeutics?

Yes, BlackRock owns 5.03% of Tenaya Therapeutics, totaling 4.07M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 12.63M$. In the last quarter, BlackRock decreased its holdings by -627K shares, a -13.34% change.

Who is Tenaya Therapeutics’s biggest shareholder by percentage of total assets invested?

Column group is Tenaya Therapeutics’s biggest shareholder by percentage of total assets invested, with 24.12% of its assets in 9.4M Tenaya Therapeutics shares, valued at 13.44M$.

Who is the top mutual fund holder of Tenaya Therapeutics shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Tenaya Therapeutics shares, with 2.66% of its total shares outstanding invested in 2.1M Tenaya Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools